107 related articles for article (PubMed ID: 24559200)
1. Elevated serum and synovial fluid TNF-like ligand 1A (TL1A) is associated with autoantibody production in patients with rheumatoid arthritis: comments on the article by Sun et al.
Cao L; Xu T; Huang C; Li J
Scand J Rheumatol; 2014; 43(2):175. PubMed ID: 24559200
[No Abstract] [Full Text] [Related]
2. Elevated serum and synovial fluid TNF-like ligand 1A (TL1A) is associated with autoantibody production in patients with rheumatoid arthritis.
Sun X; Zhao J; Liu R; Jia R; Sun L; Li X; Li Z
Scand J Rheumatol; 2013; 42(2):97-101. PubMed ID: 23311967
[TBL] [Abstract][Full Text] [Related]
3. Authors' reply.
Sun X; Li Z
Scand J Rheumatol; 2014; 43(2):176. PubMed ID: 24588514
[No Abstract] [Full Text] [Related]
4. Serum and synovial fluid levels of tumor necrosis factor-like ligand 1A and decoy receptor 3 in rheumatoid arthritis.
Xiu Z; Shen H; Tian Y; Xia L; Lu J
Cytokine; 2015 Apr; 72(2):185-9. PubMed ID: 25647275
[TBL] [Abstract][Full Text] [Related]
5. Role of TL1A in the pathogenesis of rheumatoid arthritis.
Zhang J; Wang X; Fahmi H; Wojcik S; Fikes J; Yu Y; Wu J; Luo H
J Immunol; 2009 Oct; 183(8):5350-7. PubMed ID: 19786547
[TBL] [Abstract][Full Text] [Related]
6. Soluble TNF-like cytokine (TL1A) production by immune complexes stimulated monocytes in rheumatoid arthritis.
Cassatella MA; Pereira-da-Silva G; Tinazzi I; Facchetti F; Scapini P; Calzetti F; Tamassia N; Wei P; Nardelli B; Roschke V; Vecchi A; Mantovani A; Bambara LM; Edwards SW; Carletto A
J Immunol; 2007 Jun; 178(11):7325-33. PubMed ID: 17513783
[TBL] [Abstract][Full Text] [Related]
7. Circulating TNF-like protein 1A (TL1A) is elevated early in rheumatoid arthritis and depends on TNF.
Song YJ; Choi IA; Meylan F; Demoruelle MK; Farley T; Richard AC; Hawley E; Botson J; Hong YJ; Lee EY; Mian SR; Hamilton BC; Thiele GM; Mikuls TR; Gara N; Ward CD; Lamberth S; Deane KD; Heller T; Ward MM; Lee DM; Migone TS; Stohl W; O'Dell JR; Norris JM; Holers VM; Gregersen P; Song YW; Siegel RM
Arthritis Res Ther; 2020 May; 22(1):106. PubMed ID: 32381123
[TBL] [Abstract][Full Text] [Related]
8. GITRL is associated with increased autoantibody production in patients with rheumatoid arthritis.
Li L; Wen W; Jia R; Li Y; Liu X; Sun X; Li Z
Clin Rheumatol; 2016 Sep; 35(9):2195-202. PubMed ID: 27098050
[TBL] [Abstract][Full Text] [Related]
9. Synovial fluid levels of anti-cyclic citrullinated peptide antibodies and IgA rheumatoid factor in rheumatoid arthritis, psoriatic arthritis, and osteoarthritis.
Caspi D; Anouk M; Golan I; Paran D; Kaufman I; Wigler I; Levartovsky D; Litinsky I; Elkayam O
Arthritis Rheum; 2006 Feb; 55(1):53-6. PubMed ID: 16463412
[TBL] [Abstract][Full Text] [Related]
10. Circulating levels of TNF-like cytokine 1A (TL1A) and its decoy receptor 3 (DcR3) in rheumatoid arthritis.
Bamias G; Siakavellas SI; Stamatelopoulos KS; Chryssochoou E; Papamichael C; Sfikakis PP
Clin Immunol; 2008 Nov; 129(2):249-55. PubMed ID: 18757243
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-34: a potential diagnostic and therapeutic target for rheumatoid arthritis.
He W; Xu XD; Dong YM; Wu H
J Rheumatol; 2015 Mar; 42(3):553. PubMed ID: 25729045
[No Abstract] [Full Text] [Related]
12. Association of Tumor Necrosis Like factor 1 A (TL1A) and its Decoy Receptor (DcR3) with The Disease Activity and Autoantibody Production in Rheumatoid Arthritis Patients.
Soliman MH; Ebaid AM
Egypt J Immunol; 2019 Jan; 26(1):43-54. PubMed ID: 31332995
[TBL] [Abstract][Full Text] [Related]
13. Drs. Moon and Min reply.
Moon SJ; Min JK
J Rheumatol; 2015 Mar; 42(3):553. PubMed ID: 25729046
[No Abstract] [Full Text] [Related]
14. The effects of rheumatoid factor and anticitrullinated peptide antibodies on bone erosions in rheumatoid arthritis.
van Steenbergen HW; Ajeganova S; Forslind K; Svensson B; van der Helm-van Mil AH
Ann Rheum Dis; 2015 Jan; 74(1):e3. PubMed ID: 25288634
[No Abstract] [Full Text] [Related]
15. The impact of rheumatoid factor and ACPA on bone erosion in rheumatoid arthritis.
Hecht C; Schett G; Finzel S
Ann Rheum Dis; 2015 Jan; 74(1):e4. PubMed ID: 25326218
[No Abstract] [Full Text] [Related]
16. Identification of citrullinated cellular fibronectin in synovial fluid from patients with rheumatoid arthritis.
Kimura E; Kanzaki T; Tahara K; Hayashi H; Hashimoto S; Suzuki A; Yamada R; Yamamoto K; Sawada T
Mod Rheumatol; 2014 Sep; 24(5):766-9. PubMed ID: 24498912
[TBL] [Abstract][Full Text] [Related]
17. The role of anti-cyclic citrullinated peptide and rheumatoid factor in diagnosis of rheumatoid arthritis.
Cheah TE; Sockalingam S
Int J Rheum Dis; 2012 Feb; 15(1):e1. PubMed ID: 22324958
[No Abstract] [Full Text] [Related]
18. Anti-cyclic citrullinated peptide antibody determination in the synovial fluid of patients with rheumatoid arthritis: comment on the article by Caspi et al.
Spadaro A; Riccieri V; Scrivo R; Alessandri C; Valesini G
Arthritis Rheum; 2006 Aug; 55(4):681-2; author reply 682. PubMed ID: 16874773
[No Abstract] [Full Text] [Related]
19. Increased levels of peptidylarginine deiminase 2 in synovial fluid from anti-CCP-positive rheumatoid arthritis patients: Association with disease activity and inflammatory markers.
Damgaard D; Senolt L; Nielsen CH
Rheumatology (Oxford); 2016 May; 55(5):918-27. PubMed ID: 26880831
[TBL] [Abstract][Full Text] [Related]
20. TL1A increased IL-6 production on fibroblast-like synoviocytes by preferentially activating TNF receptor 2 in rheumatoid arthritis.
Ma Z; Wang B; Wang M; Sun X; Tang Y; Li M; Li F; Li X
Cytokine; 2016 Jul; 83():92-98. PubMed ID: 27081759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
